NCT05481398

Brief Summary

To compare the rates of incisional surgical site infections (iSSIs) within 7 days of hepatopancreatobiliary (HPB) surgery using negative pressure wound therapy (NWPT) versus using standard sterile gauze dressing.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
46

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 6, 2021

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2022

Completed
27 days until next milestone

First Submitted

Initial submission to the registry

July 28, 2022

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 1, 2022

Completed
Last Updated

August 1, 2022

Status Verified

July 1, 2022

Enrollment Period

1.3 years

First QC Date

July 28, 2022

Last Update Submit

July 28, 2022

Conditions

Keywords

Hepatopancreatobiliary surgerySurgical site infectionNegative pressure wound therapy

Outcome Measures

Primary Outcomes (1)

  • Rate of incisional surgical site infections (iSSIs)

    To compare the rates of incisional surgical site infections (iSSIs) within 7 days of hepatopancreatobiliary (HPB) surgery using negative pressure wound therapy (NWPT) versus using standard sterile gauze dressing.

    within 7 days of hepatopancreatobiliary (HPB) surgery

Secondary Outcomes (5)

  • Wound infections

    day 7 till 30 days following HPB surgery

  • Surgical site complication

    within 30 days of HPB surgery

  • Rate of fascial dehiscence

    within 30 days of HPB surgery

  • Antibiotic therapy

    Day 1 to day 30

  • Length of hospital stay.

    Day 1 to day 30

Study Arms (2)

Intervention group A

EXPERIMENTAL

After the skin closed, negative pressure wound therapy will be applied.

Other: Negative Pressure Wound Therapy

Control group B

NO INTERVENTION

After the skin is closed, the wound is covered using sterile standard guaze dressing.

Interventions

The wound is dressed using negative pressure wound therapy comprising of a single layer of sterile gauze followed by placement of a 18 Fr nelaton catheter and the wound further covered with 4 more layers of sterile gauze over the nelaton catheter. The wound is then covered with opsite dressing making it airtight. The nelaton catheter is attached to the wall suction port once the patient is shifted to the bed with pressure set at - 25 mm Hg.

Intervention group A

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All patients undergoing elective open HPB surgery (benign or malignant disease) of age \> 18 years consenting to the study protocol.

You may not qualify if:

  • The patient in which primary wound closure is not achieved. The patient planned for a second look surgery. The patient with the history of long-term antibiotic use (more than a month). Past history of open abdominal surgery (less than 1 month).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sindh Institute of Urology and Transplantation

Karachi, Sindh, Pakistan

Location

MeSH Terms

Conditions

Digestive System DiseasesSurgical Wound Infection

Interventions

Negative-Pressure Wound Therapy

Condition Hierarchy (Ancestors)

Wound InfectionInfectionsPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

DrainageTherapeuticsSurgical Procedures, OperativeWound Closure Techniques

Study Officials

  • Uzma Soomro

    Sindh Institute of Urology and Transplantation

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Two individuals were assigned the role of outcome assessors to examine the wound after removal of the dressing and score the wound for infection using the ASEPSIS score.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Randomization Patients will be randomly allocated into intervention group A (NPWT) or control group (B) by simple randomization.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
General Surgery Resident

Study Record Dates

First Submitted

July 28, 2022

First Posted

August 1, 2022

Study Start

March 6, 2021

Primary Completion

July 1, 2022

Study Completion

July 1, 2022

Last Updated

August 1, 2022

Record last verified: 2022-07

Locations